March 03, 2025 09:26 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Indian woman facing death row in UAE for killing a child has been executed: Foreign ministry tells court | Crucial to have Trump’s support, says Zelenskyy a day after fiery White House exchange | 'We're looking for peace, Zelenskyy wants Russia-Ukraine war to continue': Donald Trump after White House public spat | Volodymyr Zelenskyy refuses to apologise to Donald Trump after public spat over Russia-Ukraine war | 'Make a deal or we are out': Donald Trump tells Volodymyr Zelenskyy at White House | Himachal govt seeks fund from temple to support welfare schemes, BJP calls move 'shocking' | Injustice to opposition MLAs: Atishi writes to Delhi Assembly Speaker on suspension of 21 AAP lawmakers | We will leave for US tomorrow: Father of Indian student Neelam Shinde after urgent visa grant | 'Not joining BJP or floating any party': Abhishek Banerjee dismisses rumours of his split from TMC | Pune bus rape accused arrested after 75-hour manhunt
COVID-19 Vaccine
Image Credit: Unsplash

'Well established' foreign COVID-19 vaccines makers need no bridging clinical trials in India

| @indiablooms | Jun 02, 2021, at 06:38 pm

New Delhi/IBNS: The Indian government has exempted "well established" foreign COVID-19 vaccines makers from any bridging clinical trials if it has been certified by the National Control Lab of the country where it is made, media reports said.

The testing of every batch of vaccines at Central Drug Laboratory (CDL) at Kasauli in Himachal Pradesh has also been done away with by the Drug Controller General of India or DGCI.

The exemptions are applied to the vaccines which are already approved for restricted use by US FDA, European Medicines Agency (EMA), UK MHRA, PMDA Japan or the ones listed in the World Health Organisation (WHO) Emergency Use Listing (EUL).

The decision will pave the way for pharmaceutical companies like Pfizer, Moderna to export vaccines to India, which is slowly recovering from the devastating second wave of COVID-19 pandemic.

The decision has been taken by the DGCI at a time the country is facing an acute shortage of vaccines, which are key to beat the deadly virus.

Earlier, the Punjab and Delhi governments had approached US pharmaceutical giants Pfizer and Moderna for exportation of their vaccines but the manufacturers had cleared they would only deal with the Centre in India.

Following which, Delhi Chief Minister Arvind Kejriwal had requested the Narendra Modi government to import vaccines from other countries and distribute them among the states and union territories.

So far, India has two three vaccines in hand, namely, Serum Institute of India (SII)'s Covishield, Covaxin developed by Bharat Biotech and Russia's Sputnik V.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.